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ABSTRACT OF THE DISSERTATION
MAGNETOELECTRIC NANOPARTICLES: PARADIGM SHIFT IN
BIOMOLECULAR DIAGNOSTIC
by
Chooda M. Khanal
Florida International University, 2016
Miami, Florida
Professor Sakhrat Khizroev, Major Professor
Recently discovered multiferroic nanoparticles (MFNs) known as magnetoelectric
nanoparticles (MENs) promise to revolutionize next-generation biomedical diagnostic
techniques and enable rapid and cost-effective screening of lethal diseases. Due to the
quantum-mechanically caused intrinsic magnetoelectric (ME) effect, these nanoparticles
display strongly coupled magnetic and electric moments and thus provide a unique
pathway to monitor and optionally control intrinsic characteristics of bio organisms via
application of external magnetic fields. Due to the ME effect, when placed in the
microenvironment of a biomolecular sample, MENs’ magnetic properties change to reflect
the molecular nature of the sample. Such an unprecedented intrinsic connection to cells
and microorganism’s intrinsic characteristics can pave a way to a new diagnostic paradigm.
A novel concept of portable biomolecular screening device based on continuous
wave nuclear magnetic resonance is being studied to identify microorganisms like bacteria,
virus and cancer cell lines. For the first time, MENs have been used to modify NMR spectra
and thus enable identification of different cancer cell lines from each other as well as from

vi

their normal counterparts at the sub-cellular level. This approach can be used for both in
vitro and in vivo diagnostics. In addition, blood samples of Pulmonary Arterial
Hypertension (PAH) patients with severe heart and lung conditions were used to study the
activity of MENs with prothrombin, the clotting factor of the blood. MENs has significant
interaction with prothrombin. MENS can be used for diagnostics of several diseases
associated with blood and cancer and it may be used as a therapeutic agent. The experiment
proved that the MENs are safe and nontoxic carriers of therapeutic drugs.
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1. INTRODUCTION
1.1 Bio-magnetoelectronics
A recently discovered class of multiferroic nanoparticles (MFNs) known as
magnetoelectric nanoparticles (MENs) have potential to become useful tools for diagnosis,
screening and targeted drug delivery in the near future [1-6]. These particles, which are not
only electrically polarizable or magnetically polarizable but also exhibit both properties at
the same time, are naturally designed to exploit the intrinsic characteristics of bio
organisms. Due to the quantum-mechanical origin of their magnetoelectric (ME) coupling,
these nanoparticles display strongly coupled magnetic and electric moments and thus
provide a unique pathway to monitor and optionally control intrinsic characteristics of bio
organisms via the application of external magnetic fields. The ME coupling of MENs
surface-conjugated with a biomolecular sample strongly depends on the molecular nature
of the sample and thus opens the door to a new diagnostic paradigm.
For the first time, this project is dedicated to exploiting the unique properties of
multifunctional nanoparticles for rapid screening and unprecedented diagnostic of
microorganisms and cells at the molecular level.
1.2 Background
Rapid and accurate identification of microorganisms, including bacteria and viruses,
is critical for improving the state of care of infectious diseases. A lack of rapid
identification and therapeutics, for example, allowed the 2014 Ebola outbreak to be one of
the most widely spread and persistent epidemics in recent times [7]. Recently developed
lab-on-a-chip technology that can detect the traces of Ebola virus has made it possible for
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rapid diagnostics and testing in the field, although it still requires testing in a special
biosafety facility due to the highly infectious nature of the virus [8]. Despite the world’s
focus on the Zika virus, it has not decimated spreading across the nations, thanks to the
slow and limited screening procedures [9-11]. Last but not least, the importance of the
ability to rapidly screen cell cultures for different cancers and identification of cancer at
the sub-cellular level is hard to overestimate especially today when cancer is number one
cause of death. The traditional screening approach is to use bacterial culture and
biochemical staining [12-18]. This technique, unfortunately, requires a tedious sample
preparation protocol and is relatively slow (a matter of hours and sometimes days), and is
limited to a few biomarkers. On a positive side, an advanced approach based on polymerase
chain reaction (PCR) is exorbitant to be used in most clinics and small office environments
[19,20].
In addition, it is imperative to understand the functionality of proteins in our body
that play a vital role for disease prevention and cure. There are many applications of
nanotechnology in computer engineering, sensing, biology and medicine, pathogen
detection etc.; however, not much has been done regarding the identification of diseases at
the cellular or even molecular level [2-4,21-25]. Most of the modern nanomedicine
development relates to drug delivery through blood vessels; the toxicity of nanoparticles
has been discussed but very little has been done to understand the effect of nanoparticles
on the blood coagulation system [26-29]. We attempt to give a new angle to nanoparticles
from the perspective of diagnostics at the cellular level. We use MENs to distinguish
various cancer cells from each other and from their normal counterparts, obtain the
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signature of prothrombin and its functionality using magnetoelectric nanoparticles, and
consider other applications.
Our group has for the first time designed and investigated a device for sensitive and
rapid screening for various biological entities such as bacteria, viruses, cancer cells, and
other biomolecular structures. Over the past several years, we concocted this device on the
principle of a small package and low-cost in order to make it readily available even in the
poorest healthcare facilities. This device is based on continuous wave nuclear magnetic
resonance (NMR) technology.
1.3 Motivation and Purpose
Infectious diseases caused by bacteria and viruses continue to exact a substantial toll
on health and health care resources in the USA and globally. Despite success in some areas
of disease treatment, a lack of reliable and rapid screening of such microorganisms
continue to challenge prevention and control of disease persistence [30].
Recently there has been increased interest in magnetic nanoparticle bio-sensing
(MNB) [31-33]. Due to the new dimensionality provided by the presence of externallycontrolled magnetic moments, MNB promises to enable high-specificity screening and fast
diagnostic of pathogens.

Indeed, ideally one could envision an apparatus in which

magnetic nanoparticles are used to connect the intrinsic information with regards to single
cells, e.g. the electric charge profile on the surface of a cell emerged in a specific biological
microenvironment (media), to external devices which can adequately process the magnetic
information, e.g. nuclear magnetic resonance (NMR), magnetic resonance imaging (MRI),
magnetic particle imaging (MPI), vibrating sample magnetometry (VSM), B-H looper for
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susceptibility measurements, magneto-optical Kerr microscopy, magnetic force
microscopy (MFM), and others [34-36].
The other motivation of this dissertation is to maximize the drug delivery capabilities
of the same nanoparticles used for screening. Studying the above diagnostic application
involves deep understanding of mechanisms of the molecular interaction between
nanoparticles and the microorganisms at the sub-cellular level and development of ways to
control these intrinsic mechanisms. The knowledge obtained through this study is critical
also for improving the more popular drug delivery applications of nanoparticles. For
example, this knowledge will help achieve full payload carrying capacity and delivery of
the fully loaded cargo in a manner where release close to 100% of the therapeutic drug is
released on site and on-demand [2-4,37,38]. In modern drug delivery approaches,
therapeutic drugs are attached to nanoparticles via covalent, non-covalent (electrostatic,
Van der Waal, hydrogen), or ionic bonds. Modifying the surface properties (i.e. by
controlling the surface charge and polarity) of the nanoparticles and their functionalization
plays a key role in improving the attachment of the drug. Such goals are also being pursued
in this particular study.
Most of the current nanoparticle based drug delivery systems are relatively inefficient
due to their strong dependence on the intrinsic properties of the cell’s physiological
conditions such as temperature, pH, enzymatic reactions, and others to deliver the cargo
drug. As a result, the drug releasing process is extremely inefficient due to the dependence
on the minute changes in the physiological conditions in the microenvironment of the cell.
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Using MENs instead of the traditional nanoparticles can overcome this roadblock because
MENs provide an additional dimension to control delivery and release of the drug.
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2. MAGNETOELECTRIC NANOPARTICLES
2.1 What is magnetoelectric nanoparticles
Multiferroic nanoparticles (MFNs), which sometimes include the category of
particles called magneto-electric nanoparticles (MENs), simultaneously show the
properties of ferromagnetism and ferroelectricity. These MEN particles are magnetically
as well as electrically polarizable and show all the properties- ferromagnetic, ferroelectric,
multiferroic, and magnetoelectric. MFMs exhibits a strong quantum coupling of magnetic
and electric properties and come under the multiferroic category, as they demonstrate both
ferroelectric and ferromagnetic properties simultaneously [1,5,6].
Figure 1 shows the relationship between the magneto-electric and multiferroic
materials. Borocite (Ni3B7O13I) was the first material reported to exhibit magneto-electric
switching below 60 K [39]. Magnetoelectric effect in composite materials is the product
tensor property given by the product of magnetostrictive effect (magnetic/ mechanical
effect) in the magnetic phase and the piezoelectric effect (mechanical/ electrical effect) in
the ferroelectric phase [40]. Magnetic to electric energy conversion exploits the advantages
of properties from two different phases of the material, i.e. from the ferromagnetic phase,
piezomagnetic or magnetostrictive property and from the ferroelectric phase, piezoelectric
or electrostrictive property. Thus, when an external magnetic field (ΔH) is applied,
magnetostrictive stress formed in the magnetic phase is transferred to the ferroelectric
phase changing the polarization (ΔP) and the associated electric field (ΔE) due to the
piezoelectric effect. Performance of magnetoelectric materials is determined by this
transfer efficiency, which is referred to as the magneto-electric coefficient (α = ΔP / ΔH)
or as the magneto-electric voltage coefficient (αE = ΔE / ΔH). Magneto-electric coefficients
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of various multiferroic materials are shown in Table 1. Electric flux density (D) in
multiferroic materials as shown in the following equation is determined by the magnetoelectric coefficient tensor (αij), permittivity tensor (εij), and the piezoelectric coefficients
(eij) in an applied vector magnetic, electric field, and external stress S [1,41].
𝑗−3

𝐷𝑖 = ∑

𝑗−1

𝑗−6

𝜀𝑖𝑗 𝐸𝑗 + ∑

𝑗−1

𝑗−3

𝑒𝑖𝑗 𝑆𝑗 + ∑

𝑗−1

𝛼𝑖𝑗 𝐻𝑗

Figure 1: The relationship between the magneto-electric and multiferroic materials.
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Morphology

Materials

Composite
Composite
Laminated
composites
Laminate
Laminate
Laminate

BaTiO3 and CoFe2O4
Terfenol-D and PZT in polymer matrix
Terfenol-D in polymer matrix/PZT in polymer
matrix
Terfenol-D/PZT
La0.7Sr0.3MnO3/PZT
NiFe2O4/PZT

ME
coefficient

Ref

50
42

[42]
[43]

3,000

[44]

4,800
60
1,400

[45]
[46]
[46]

Table 1: Magneto-electric coefficients in two-phase systems.
Magnetoelectric materials can be used in two forms, i.e. either in the laminate form
or in the particulate form. Using magnetoelectric materials in the particulate form is often
the better option because of the excellent magneto-electric properties caused by the
following reasons:
a. Shape effects: spherical shape of the particles provides better transfer of
magnetostrictive stress from magnetic phase to the ferroelectric phase.
b. Zero-substrate clamping effect: laminates/films needs to be clamped, which
restricts the magnetostrictive strains.
c. Binding efficiency: mechanical contact in the interface of particulate
composites is much higher as compared to the laminate/films composites.
(Note: laminate/films composites need to be either glued or sintered which
often results in poor binding efficacies).
So far, magnetoelectric materials are extensively used in microwave filters, signal
amplification devices, data storage devices, transducers, optical-diodes, power generation
systems, high frequency switches, miniature-antennas, and spintronics [47-54], but in this
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dissertation, we present the biomedical applications of the magnetoelectric materials
especially the application of detection of microorganisms.
MENs, also called “smart” nanoparticles, can controllably regenerate important
physical functions on the surface of the cellular microorganism being tested. The MEN’s
underlying physics is a very intricate quantum-mechanical coupling between magnetoelectric spinel and ferromagnetic perovskite structures. This coupling allows the use of
external magnetic fields to control local electric fields for sub-cellular diagnostic and
targeted drug delivery into specific cells [55,56].
2.2 Novelty and significance of the proposed nanotechnology
Due to the new dimensionality provided by the presence of externally-controlled
magnetic moments, in magnetic nanoparticles, we have the capability to enable highspecificity screening and fast diagnostic of pathogens. Indeed, ideally one could envision
an apparatus in which magnetic nanoparticles are used to connect the intrinsic information
with regards to single cells, e.g. the electric charge profile on the surface of a cell emerged
in a specific biological microenvironment (media), to external devices which can
adequately process the magnetic information, however, the current progress in the area of
novel technologies is still relatively slow.

The challenge is to “connect” magnetic

nanoparticles to the intrinsic information at the cellular or intra-cellular level.

The

fundamental nature of this intrinsic information is reflected in its electric-field
characteristic; all of the previously mentioned microorganisms and cell structures have
signature surface proteins/receptors which are inclined to be electrically polarized in a
certain biological microenvironment and which are also the main binding sites for
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nanoparticles. The charge on different cell surfaces does not only differ by its amount but
also by its distribution. Unfortunately, it is difficult to measure this information directly
using electric fields alone because electric fields experience significant interference when
they go through the media and as a result direct physical contacts would be required, which
then makes the measurements both difficult and costly.

In addition, the traditional

approach of using nanoparticles for bio-sensing and as a drug delivery platform lacks the
sufficient targeted delivery in a controlled environment application. Therefore, to
overcome all the above challenges associated with the traditional magnetic nanoparticles,
we have chosen to exploit MENs.
MENs can be used to enable externally controlled passive targeted delivery and
release of therapeutic loads, e.g. specific peptides for regulating cell proliferation with high
selectivity. Unlike modern active-targeting nanotechnology approaches, e.g. antibody- or
ligand mediated therapies that interact with the immune system, MENs do not rely on the
immune system to target the diseased cells. Instead, MENs use a physical force that is
driven by the Coulomb interaction, which is self-triggered when the nanoparticles circulate
past the targeted cells with a specific electric-field signature. This self-triggering
mechanism can be either “pre-programmed” via defining the MENs saturation
magnetization and the ME coefficient through a fabrication process or via application of
an external magnetic field. Unlike conventional passive targeting, like enhanced
permeability and retention (EPR), MENs do not need relatively large cell aggregates for
targeting [57,58]. MENs-driven passive targeting is achieved at the cellular level through
detection of specific stray electric field profiles.
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The drug-loaded MENs cross the membrane through field induced “nanoelectroporation” and release their load on demand. We proved our novel technique to show
that the anti-cancer drug loaded in our smart particles penetrated through the membrane
and completely eradicated tumor cells within 24 hours without affecting the normal cells
[2,4]. We have also demonstrated the externally controlled on-demand release of anti-HIV
drug using our smart nanoparticles as carriers [3].
Moreover, the fact that each cell possesses a unique intrinsic electric characteristic,
MENs may also be used as magneto-electronic biomarker. Some cancer cannot be treated
completely and also passes from generation to generation. The most common cause of
treatment failure in acute lymphoblastic leukemia (ALL) remains relapse, occurring in
approximately 15 to 20 percentage of patients [59-61]. In other words, a child with ALL
may seem to be cured completely with chemotherapy treatment however about 15 to 20
percentage of the time it appears again during adulthood. The cancerous traces hidden in
brain or sometimes in testicles (testicular relapse in male) cannot be treated by the
conventional chemotherapy and remains unknown for years. There is no other way of
finding out if the cancerous traces are still there in the body after treatment. So, exploiting
the electric property of such cells with the MENs as a magneto-electronic biomarker may
lead to the path of diagnosis and targeted therapy of such diseases.
Before we proceed, once again we would like to stress the importance of not
confusing MENs with traditional magnetic nanoparticles (MNs) and the novelty and
significance of proposed nanotechnology based on MENs. One of the importance of MENs
over the traditional magnetic nanoparticles (MNs) is shown in Figure 3. MENs were 30-
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nm coreshell CoFe2O4@BaTiO3 nanostructures consisting of the ferrimagnetic spinel core
CoFe2O4 and the piezoelectric perovskite shell BaTiO3. MNPs were 20-nm CoFe2O4
ferrimagnetic nanostructures.
Following is the M-H characteristics and blocking temperature measurement plot
using vibrating sample magnetometer physical property measurement system (PPMS). A
room-temperature Lakeshore vibrating sample magnetometer (VSM) with a 3-T magnetic
field sweep was used to measure key magnetic properties of nanoparticles under study
including the magnetization saturation and the magnetic coercivity. A cryogenic VSM
Quantum Design PPMS with a 9-T superconducting magnet was used to measured M-H
temperatures in a wide temperature range, from 4K to over 300K.

Figure 2. (a) M-H hysteresis loops for 30-nm MENs measured in a wide temperature range
from 4 to 300 K. The inset shows A TEM image showing a coreshell structure of 30-nm MENs.
b) Blocking temperature measurement curves including zero-field cooling (ZFC), field
cooling (FC) and field warming (FM) curves at a field of 100 Oe.
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Figure 3: (a) and (b) show M-H hysteresis loops of 30-nm MENs and traditional 20-nm
magnetic nanoparticles (MNs) without any ME effect, respectively, measured via vibrating
sample magnetometry (VSM).

To understand the MENs’ temperature dependence, typical M-H hysteresis loops
of MENs in a temperature range from 4 to 300 K obtained via a cryogenic vibrating sample
magnetometer Quantum Design PPMS are shown in Figure 2(a). The standard
magnetization versus temperature curves under zero field cooling (ZFC) and non-zero field
cooling (FC) conditions to determine the blocking temperature are shown in Figure 2(b).
The blocking temperature is the temperature above which the nanoparticles become
superparamagnetic. In this case, it is above 300 K, which confirms that the nanoparticles
are not superparamagnetic at room temperature despite their small size. The ME
coefficient, α, for these nanostructures is known to be in the range from 10 to over 100 mV
cm-1 Oe-1.
From the loops in Figure 3, one can see that MENs and MNs have saturation
magnetizations of approximately 1 and 40 emu/g, respectively, and coercivity fields of
approximately 310 and 90 Oe, respectively.
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2.3 Preparing magnetoelectric nanoparticles
2.3.1 Magnetoelectric nanoparticles (Core)
CoFe2O4 particles (core) were prepared by the standard hydrothermal method
[2,62]. 0.58 grams of Cobalt Nitrate (Hexahydrate) reagent [Co(NO3)2.6H20] and 1.6 grams
of ferric nitrate [Fe(NO3)3.9H20] were dissolved in 150 milliliters of distilled water taken
in a beaker. In a second beaker 2 grams of polyvinylpyrrolidone and 9 grams of sodium
borohydride were dissolved in 50 ml of distilled water. The two aqueous solutions were
mixed by gently adding drop by drop from the second beaker to the first one using pipette
and continuously stirring at 320 rpm and then 1000 rpm. During this process, the beaker
was placed in a heater at 70°C. After the solution is completely incorporated, the stirrer
was set to 300 rpm and the temperature was set to 90°C for overnight (12 hours). Similar
procedures for the preparation of core are implemented in the Personalized Nanomedicine
lab at FIU for previously published journals [2-4].

2.3.2 Precursor solution
To prepare the precursor solution of BaTiO3, two beakers were taken. 150 mL of
ethanol was mixed with 5 grams of citric acid and 240 uL of titanium (IV) ispropoxide in
the first beaker. 1 gram of citric acid and 0.145 gram of barium carbonate was dissolved in
the second beaker containing 150 mL of deionized (DI) water. The two solutions were
mixed and sonicated for 60 minutes.
Coreshell CoFe2O4-BaTiO3 multiferroic nanoparticles were prepared by mixing 0.5
g of CoFe2O4 nanoparticles core in the BaTiO3 precursor solution and the mixture was
sonicated for 2 hours. Once the CoFe2O4 nanoparticles were thoroughly dispersed, the
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mixture was dried on the hot plate at 70°C overnight while continuously stirring. The
obtained polymer precursor was subjected to 500°C (for 10nm), 600°C (for 30 nm), 700°C
(for 100nm) for 5 hours in a furnace (CMF-1100).
The prepared samples were imazed for the size verification. We used scanning
probe miscroscopy, Transmission Electron Microscopy (TEM) [63] and Atomic Force
Microscopy (AFM) [64]. All the samples were verified before use. TEM is an imaging
technique where a beam of electrons is transmitted through a sample interacting with it as
it passes through it. The image is formed by the interaction of the beams with the sample,
details explained elsewhere [63]. Figure 4 is an image of a 30 nm sample taken by TEM.
It clearly shows the two-phase core shell nature of MFMs. The scale bar is 100 nm.
Similarly, we took TEM images of 10 nm and 100 nm nano particles as well (not shown
here).

100 nm
Figure 4: Transmission Electron Microscopy (TEM) image showing the two-phase coreshell nature of 30 nm MENs.
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The Atomic Force Microscope cannot show the two phase shell due to its different
nature of imaging. The image is taken by feeling or touching the surface of the sample my
its mechanical probe, and not by transmitting through the sample as in TEM. AFM takes
an image by the reaction of the probe to the forces that the sample imposes on it as the tip
of AFM runs across the surface of the sample that can be used to form an image of the
three-dimensional shape (topography) of a sample surface at a high resolution. It can show
the size of the particles in nanometer scale. Figure 5 and Figure 6 are the screen shot images
of 10 nm and 100 nm respectively taken my AFM.

Figure 5: Screen shot of AFM image of 10 nm nano-particles.
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Figure 6: Screen shot of AFM image of 100 nm nano-particles.

The radius of curvature of AFM tip is on the order of 10 nm, so there is always an
additional margin of about 20 nm on the horizontal distance of the sample. For example,
Figure 4 shows an image of 100-nm nanoparticles. The curser is placed at the two
extremities of the particle and the horizontal distance shows about 130 nm. The average
size of the particles is 100 nm. Similarly, Figure 3 is an image of 10 nm particles. The
curser is placed at one edge and the center of the particle to measure the vertical distance
of the particle rather than the horizontal distance. If the particle size is on the order of the
radius of curvature of the tips, it is better to take the vertical distance to measure the particle
size. Due to the difference in vertical and horizontal positioning approaches, the vertical
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distance and each of the two horizontal distances are measured with precisions of
approximately 1 and 10 nm, respectively.

2.3.3 Coating of intermediate layer
Due to the ultra-fine size of MENs and the low toxicity, they are promising
candidates for medical applications.

However, since the medicated particles are

transported via blood, their sizes, surface charge and ME chemistry strongly affects the
bioavailability of the particles inside the body. Not to mention that under some cases, if not
properly treated and/or functionalized, the nanoparticles may become toxic and may not
properly function for the desired external magnetic field for targeted delivery. Specific
experiments require controllable dissociation of drug molecules from the nanoparticle
surface by selecting appropriate intermediate layers, such as Glycerol monooleate (GMO),
Tween-20, or Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC). In our experiment
we used a 2 nm of the intermediate layers of GMO and EDC.

In both cases (to coat with GMO and EDC, respectively), as the first step 20 mg of
MENs were added to phosphate-buffered saline (PBS) buffer solution. Then, 40 uL of
GMO solution (1 mg/ml) was added to the solution and incubated for an hour while slowly
rotating to achieve uniform coatings. After completing the incubation process, the particles
were washed by centrifuging to 33,000 revolutions per minute (rpm) for 5 minutes. After
spinning, any GMO bubbles and PBS were removed gently. PBS was added again to the
sediments, vortexed, and centrifuged again to 40,000 rpm for 5 minutes. The washing
process was repeated 3 to 4 times until all unbounded GMO was completely removed from
the solution.
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We used Energy Dispersion Spectroscopy (EDS), an analytical technique used for
the elemental analysis or chemical characterization of a sample. Phillips CM-200 200 kV
Transmission Electron Microscope (TEM) with Energy Dispersive Spectroscopy (EDS)
option was used to obtain TEM images and EDS profiles. Figure 7 shows the composition
of MENs and Figure 8 depicts the composition of GMO coated nanoparticles.

Figure 7: Energy dispersion spectroscopy (EDS) results depict the composition of
magnetoelectric nanoparticles.
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Figure 8: Energy Dispersion Spectroscopy (EDS) results depict the composition of GMO
coated magnetoelectric nanoparticles.
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3. DEVICE PRINCIPLE AND DESIGN
3.1 Background
We designed a nanodevice for rapid screening and signature identification of cells
and other microorganisms. We investigated the invention on cancer cells, different
bacteria, viruses, prothrombin and other biomolecular structures over the course of several
years. The principle of this cost effective and small package format device is based on
continuous wave nuclear magnetic resonance (NMR) technology. NMR is a physical
phenomenon in which nuclei in a magnetic field absorb and re-emit electromagnetic
radiation. The energy is at a specific resonance frequency which depends on the strength
of the magnetic field and the magnetic properties of the atoms. Protons and neutrons inside
the nucleus of an element possess a magnetic dipole moment () which is similarly
characterized by an intrinsic spin quantum number like an electron spin. If a nucleus has
an even number of nuclei for example 12C6, which has 6 protons and 6 neutrons, these spins
are paired against each other summing to zero overall spin or magnetic dipole moment.
However, in nuclei like 1H1 and 19F9, the nucleus does not possess a net zero spin, so these
nuclei have a finite magnetic dipole moment.
It is commonly recognized that sensitive and rapid identification of blood cells and
microorganisms including bacteria and viruses is critical for improving the state of care of
infectious diseases. The traditional approach is to use bacterial culture and biochemical
staining. Unfortunately, this technique requires a tedious sample preparation procedure and
is thus relatively slow (a matter of hours and sometimes days), and, not to mention, is
limited to a few notable biomarkers. A more advanced approach based on polymerase chain
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reaction (PCR) remains cost-ineffective for being used in most clinics and small office
environments.
Therefore, there has recently been increased interest in magnetic nanoparticle biosensing (MNB). Due to the new dimensionality provided by the presence of externallycontrolled magnetic moments, MNB promises to enable high-specificity screening and fast
diagnostic of pathogens.

Indeed, ideally one could envision an apparatus in which

magnetic nanoparticles are used to connect the intrinsic information with regards to single
cells, e.g. the electric charge profile on the surface of a cell located in a specific biological
microenvironment (media), to external devices which can then adequately process the
magnetic information, e.g. nuclear magnetic resonance (NMR), magnetic resonance
imaging (MRI), magnetic particle imaging (MPI), vibrating sample magnetometry (VSM),
B-H looper for susceptibility measurements, magneto-optical Kerr microscopy, magnetic
force microscopy (MFM), and others [31-36].
However, the current progress in the area of novel technologies is still relatively
slow. The challenge is to “connect” magnetic nanoparticles to the intrinsic information at
the cellular or intra-cellular level. The fundamental nature of this intrinsic information is
reflected in its electric-field characteristic; all the previously mentioned microorganisms
and cell structures have signature surface marker proteins and receptors which are inclined
to be electrically polarized in a certain biological microenvironment and which are also the
main binding sites for nanoparticles. The charge on different cell surfaces does not only
differ by its amount but also by its distribution. Unfortunately, it is difficult to measure
this information directly using electric fields alone because electric fields experience
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significant interference when they go through the media and as a result direct physical
contacts would be required, which makes the measurements difficult and costly.
Therefore, the underlying physics of our invention relies on using magnetoelectric
nanoparticles (MENs) to convert the electric charge information stored on the cell surface
into a certain magnetic field pattern which could be quickly measured by external magnetic
measurement setups such as NMR, VSM, MOKE magnetometry, B-H looper, or others.
3.2 Device Principle
The first embodiment would be in the form of a rapid NMR sweeper (it can be
frequency or magnetic field sweep). The schematic in Figure 9 is not to scale but illustrates
the basic components of the setup. The entire prototype apparatus in the lab is quite portable
and would easily fit in a regular backpack. A more advanced embodiment would consist
of a miniaturized battery-supplied integrated circuit chip, which could be purchased in a
neighborhood pharmacy store. In the future, such an integrated chip for rapid bacteria/virus
identification could be carried in a pocket or attached to everyday clothing; the chip would
be wirelessly connected to a computing device such as a smart phone, watch, laptop, or
another, which in turn would provide the constantly updated database of spectra for
different bacteria and viruses; such a database could be shared through the internet.
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Figure 9: A basic device implementation for rapid screening of bacteria, viruses, and other
cellular microorganisms.

The current device is quite portable in that it will fit inside a regular bag or
backpack. A future device implementation would be in the form of an integrated microchip,
which could be carried in a pocket or integrated in everyday clothing. In this case, a patient
sample under study would optionally emerged be integrated into a special media, with the
nanoparticles uniformly distributed in the media, to enhance the charge accumulation on
specific surface sites characteristic of the sample. For example, in case of a virus, it could
be put in a special stabilizing solution (which would also preserve the integrity of the
sample) with a neutral physiological pH, such as Tris-EDTA buffer solution, PBS, or
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another, to enhance the charge presence at low-dimensional irregularities (protruding
proteins, receptors, etc.) on its surface where the charge would be more strongly
accumulated (localized) to reflect the signature characteristics of this particular virus
(Figure 10).

Figure 10: Schematic illustration of a HIV virus with characteristic protruding proteins/
receptors. Nanoparticles bind to these proteins.

As the nanoparticles bind to the characteristic surface sites, the nanoparticles are
subjected to local electric fields due to the signature charge accumulations. Because of the
unique magnetoelectric (ME) coefficient, these local electric fields generate local magnetic
fields, which in turn superimpose with the magnetic field generated by the NMR setup.
The NMR signal, i.e. the electromagnetic energy absorption, is generated when the
resonance condition, ℎ𝑣 = 𝑀𝑛 𝐻𝑛𝑒𝑡 is satisfied, where h is the Plank constant, v is the
frequency of the electromagnetic wave (usually in kHz range in the NMR setup), Mn is the
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nuclear spin measured in NMR (usually, proton spin), Hnet is the net magnetic field. This
local net field is made of the two contributions, (i) the external field generated by the NMR
magnets, H0, and contribution due to the ME effect of MENs on the surface of the virus,
HME, respectively: 𝐻𝑛𝑒𝑡 = 𝐻0 + 𝐻𝑀𝐸 .

As a result, each NMR spectrum will reflect the surface charge contribution of
specific cells. Examples using bacteria, virus, and blood cells are presented in the
proceeding chapters.
To confirm the underlying mechanism of the nanoparticles binding to specific sites
on viral and bacterial surfaces, the following atomic force microscopy (AFM) experiments
were conducted with several different strains of bacteria (Figure 12 through 15). AFM
directly measures the surface topography with a nanometer spatial resolution. It could be
mentioned that the viral surfaces display even more pronounced differences and therefore
would result in a more significant effect. However, for the sake of simplicity, we first
focused on the bacteria, which were currently available in our laboratory.
The respective NMR spectra measured for different bacteria strains are shown in
Chapter 4.

Two embodiments of MENs, uncoated nanoparticles, and nanoparticles

functionalized with a thin layer glycerol monooleate (GMO), respectively, are shown.
As embodiment complementary application, the setup can be used to identify
different cell types, including normal and cancer cells of the same or different types at
different cancer progression stages. The physical origin of the charge accumulation on the
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surface is somewhat different between viruses and cells since viruses lack sophisticated
membrane structure like that found on cells. In addition to the preferred binding sites due
to specific proteins/receptors/etc., the accumulated charge strongly depends on the electric
charge capacity of the cell membrane. For example, the charge stored on the cancer cell
membrane is significantly smaller than that on the normal cell membrane of identical type.
Additionally, the capacity depends on the cancer progression stage. Therefore, the charge
contribution of the cell membrane is complex and made of several components.

Figure 11: Spectra of normal cell line (red), cancer cell line f7 (black) and t47 (green)

As an example, we used our biosensing technology to measure the spectra of three
cell lines including a normal cell line (red line 12a) and two cancer cell lines f7 and t47 at
different progression stages, as shown in Figure 11. Clearly, the spectrum for the normal
cell line has a distinctly different parabolic dependence compared to the cancer cell lines.
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In turn, the two cancer cell lines are different quantitatively. Experimental design and
measurement is described in detail in Chapter 5.
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4. SIGNATURE IDENTIFICATION OF BACTERIAL SAMPLE
4.1 Background
Rapid and accurate identification of microorganisms like bacteria is critical for
improving the state of care of infectious diseases. Lack of rapid identification and
therapeutics of bacterial infection epidemics has a significant growth in recent times. As
described in chapter 1.2, recently developed lab-on-a-chip technology that can detect the
traces of certain bacteria and viruses has made it possible for rapid diagnostics and testing
in the field, although it still requires testing in a special biosafety facility. The traditional
screening approach is to use bacterial culture and biochemical staining. This technique,
unfortunately, requires a tedious sample preparation protocol and is relatively slow (a
matter of hours and sometimes days), and is limited to a few biomarkers. On its north, an
advanced approach based on polymerase chain reaction (PCR) is exorbitant to be used in
the most clinics and small office environments. In order to solve the problem, our group
has designed and investigated a device as, described in chapter 3, for sensitive and rapid
screening for various biological entities such as bacteria, viruses, cancer cells, and other
biomolecular structures. Over the past several years, we concocted this device on the
principle of a small package and low-cost in order to make it readily available even in the
poorest healthcare facilities. This device is based on continuous wave nuclear magnetic
resonance (NMR) technology.
4.2 Sample preparation
First, we used bacterial samples to get establish their signature signals using NMR. LB
media plates were streaked with frozen culture stock and incubated overnight. Single
colony inoculated LB media was incubated overnight on a shaker. Cells were washed with
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and resuspended in saline. Optical density was adjusted and normalized with saline to
achieve an OD600 of 1x or 3x. Bacteria was incubated with MENs for 30 minutes at room
temperature on a rotator. Specific amounts used for each experiment are listed beside
results. Samples were prepared in triplicates. We used TEL cws 12-50 Advanced
NMR/ESR System and its accompanying software to sweep the field or the frequency.
Glass capillary tubes delivered the solution into the reader. The B0 was initially adjusted
with a MENs only solution before any measurements were taken, and was also periodically
adjusted as needed to mitigate expected shift in between readings. The graphs presented
are averages of the 3 samples used.
A triplicate of each Pseudomonas aeruginosa, Escherichia coli, Serratia
marcescens, and Bacillus cereus was used for each experiment and the same samples were
used for to prepare slides for Atomic Force Microscope (AFM) and Scanning Electron
Microscope (SEM) imaging. These bacterial strains were selected to demonstrate a variety
of possible pathogens that could be detected with this system.
The AFM images shown in Figure 12 through Figure 15 shows the surface
morphology of pseudomonas aeruginosa, escherichia coli, serratia marcescens, and
bacillus cereus respectively. Top two figures are images of samples without nanoparticles
while the bottom two are with particles. The left side images are the height maps whereas
the right ones are the amplitude. The height maps on the left do not really look like the real
bacteria as it appeared in the SEM images and such images do not display
easily the shape of the features. Ways around this include shading the image, and more
commonly, creating a pseudo-3D image from the height data. However, the deflection (or
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amplitude) images are equivalent to a map of the slope of the sample, so they often display
the shape of the sample more clearly. The z-scale in deflection or amplitude is completely
meaningless in terms of the sample structure. All it shows is how the tip deflected as it
encountered sample topography. Nevertheless, the AFM images could not clearly show the
topography of binding MENs to the surface of the bacteria. The 10 m scale AFM image
does not show good MENs binding with the bacteria due to low resolution and sensitivity.
Some bacteria like bacillus cereus may not interact strongly with the MENs. SEM images
(Figure 16 through Figure 19) shows better clustering of particles with bacteria.

Figure 12: AFM image of Pseudomonas aeruginosa in a medium without MENs (top two)
and with MENs (bottom two)
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Figure 13: Figure 3.5: AFM images of Escherichia coli in a medium without MENs (top
two) and with MENs (bottom two)

Figure 14: AFM images of Serratia marcescens in a medium without MENs (top two) and
with MENs (bottom two).
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Figure 15: AFM images of Bacillus cereus in a medium without MENs (top two) and with
MENs (bottom two).

The following SEM images Figure 16 through Figure 19 shows the clustering of
MENs with the bacteria. The SEM images shown in Figure 16 through Figure 19 show the
surface morphology of pseudomonas aeruginosa, escherichia coli, serratia marcescens, and
bacillus cereus respectively. Top two figures are images of samples without nanoparticles
while the bottom two are those with particles. The left side images are with the lower
magnification and the right ones are with higher magnification (resolution) as shown in the
labels at the bottom bars of each images.
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Figure 16: SEM images of pseudomonas aeruginosa without MENs (top two) and with MENs
(bottom two) with different magnifications as shown in the label.

Figure 17: SEM images of escherichia coli without MENs (top two) and with MENs (bottom
two) with different magnifications as shown in the label.
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Figure 18: SEM images of serratia marcescens without MENs (top two) and with MENs
(bottom two) with different magnifications as shown in the label.

Figure 19: Figure 3.11: SEM images of bacillus cereus without MENs (top two) and with
MENs (bottom two) with different magnifications as shown in the label.
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4.3 Device optimization and bacterial measurement
Device was designed as described in Chapter 3. The TEL cws 12-50 Advanced
NMR/ESR System was optimized for the measurement of the bacterial sample. The
absorbance of the sweep comes from the nanoparticles in the solution, meaning that a
higher concentration of particles causes a greater absorbance (Figure 20 A). The optimal
concentration for testing was selected to be 50 mg/ml as it resulted in the largest increase
in absorption coupled with the smallest standard deviations. The saline solution and
bacterial cells give only a very weak background signal (Figure 20 B).

Figure 20: NMR Absorbance. A) Nanoparticles in the solution determine the strength of the
absorbance. B) Bacterial solutions have a very weak absorbance.
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Figure 21: Pelleted 1 ml 1X bacteria, suspended in 20 l saline, added 20 l 50 mg/ml
MENs.

Next, the optimal phase for the field sweep was determined to be around 300 (Figure 22)
and 297 was used for all readings. MENs were determined to the superior identifier of
bacteria compared to magnetic nanoparticles and GMO-coated MENs (Figure 23).
Frequency sweep results confirm patterns seen in the field sweep used (Figure 24).
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Figure 22: Phase Optimization for MENs. A) MENs signal is strongest around a phase of 300. B)
An example of a solution of bacteria with no MENs showing weak signal even at optimized
settings.

Figure 23: MENs Provide Best Blind Differentiation. A) MENs being used to identify blinds.
B) Traditional magnetic nanoparticles being used to identify blinds. C) GMO-coated MENs
being used to identify blinds.

38

Figure 24: Frequency Sweep. The field sweep data used is consistent with the frequency
sweep data, but is not better for identifying bacterial blinds.
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Figure 25: A) Four bacterial species were used to demonstrate the unique MENs
interacting properties of each. B) Blind identities were successfully determined using the
reference: 1=S. marcescens, 2=B. cereus, 3=P. aeruginosa, 4=E. coli.

Exploitation of intrinsic surface electromagnetic properties of biological organism
works as a tool for biomedical signature and screening.
The direct curves were analyzed to plot the signature curves of all four bacteria
using moving average fit curve. The background curve due to MENs only were removed
to get the signature of the bacteria only. Following are the eyeball comparison of each
bacterium with MENs and corresponding signature curve.
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Figure 26: Eyeball comparison of MENs and Bacillus Cereus
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Figure 27: Signature curve of Bacillus Cereus
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Figure 28: Eyeball comparison of MENs and Serratia marcescens
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Figure 29: Signature curve of Serratia Marcescens
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Eyeball Comparision of MENs and E. Coli
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Figure 30: Eyeball comparison of MENs and Escherichia Coli
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Figure 31: Signature curve of Escherichia Coli
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Figure 32: Eyeball comparison of MENs and Pseudomonas Aeruginosa
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Figure 33: Signature curve of Pseudomonas Aeruginosa
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Figure 34: Signature curves of Bacillus Cereus (blue), Serratia Marcescens (red),
Escherichia Coli (green), and Pseudomonas Aeruginosa (purple)

Signature curves of all four bacteria are unique. Although the signature curve of
Serratia Marcescens (Figure 29) and Escherichia Coli (Figure 31) seems quite close but
they are clearly distinguishable. Optimization and proper calibration of MENs
concentration, sample preparation, precise measurement and proper signal processing
application design will eliminate the doubt if any. The experiments on bacterial sample
shows that the MENs could be used not only to distinguished between their counterparts
but also with other types of cells.
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5. SIGNATURE IDENTIFICATION OF CANCER CELL LINES

5.1 Background
Rapid identification of cancer cells is vital for cancer prevention and treatment.
Traditional techniques which rely on biochemical staining require a tedious sample
preparation and are limited to a few biomarkers. A more advanced approach based on
polymerase chain reaction (PCR) remains cost-ineffective in a small-clinic environment.
Therefore, recently there has been increased interest in magnetic nanoparticle biosensing
(MNB). Due to a new dimensionality provided by the presence of externally-controlled
magnetic moments, MNB promises to enable high-specificity screening and fast diagnostic
of pathogens.

Indeed, ideally one could envision an apparatus in which magnetic

nanoparticles are used to couple intrinsic information related to single cells, e.g. the electric
charge profile on the surface of a cell in a specific biological microenvironment, to an
external magnetic device such as a nuclear magnetic resonance (NMR) system. However,
the current progress in this area still remains relatively slow. The main challenge is to
couple magnetic nanoparticles to intrinsic information at the cellular or intra-cellular level
with sufficiently high efficacy to be able to process the information with a magnetic system.
While the system measures magnetic fields, the intrinsic cellular information is reflected
in electric fields. It can be noted that in the cellular microenvironment, each cell structure,
corresponding to a specific cancer type and a cancer progression stage, is characterized by
a certain membrane surface morphology which in turn results in a signature electric-field
configuration [65-67]. However, traditional purely magnetic nanoparticles wouldn’t be
able to detect this complex electric-field configuration, unless they have electric charges.
To address this problem, in lieu of the traditional magnetic nanoparticles, we have used a
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type of multiferroic nanoparticles known as magnetoelectric nanoparticles (MENs). Unlike
the traditional magnetic nanoparticles, MENs have both magnetic and electric dipole
moments; in addition, these two different moments are correlated through the
magnetoelectric (ME) effect. Due to the presence of an electric charge MENs preferentially
attach to cell-specific sites, while due to the ME effect MENs allow to convert the intrinsic
electric field information at the cellular level into a specific magnetic field pattern which
in turn could be measured through a magnetic measurement setup such as an NMR system.
Because each cell type has its own signature electric field distribution, such NMR
measurements could be used to distinguish different cell types from each other at the intracellular level.
5.2 Sample preparation and cell culture
MENs were prepared as described in chapter 2.3. CoFe2O4-BaTiO3 core shell
MENs were prepared according to the following conventional procedure. As the first
step, CoFe2O4 particles were prepared by the standard hydrothermal method, according
to which 0.058 g of Co(NO3)2.6H20 and 0.16 g of Fe(NO3)3.9H20 were dissolved in 15
ml of distilled water and 0.2 g of polyvinylpyrrolidone was dissolved in 5 ml of aqueous
solution containing 0.9 g of sodium borohydride at 120°C for 12 hours. Then, a
precursor solution of BaTiO 3 was prepared by mixing 30 ml of aqueous solution
containing 0.029 g of BaCO3 and 0.1 g of citric acid with 30 ml of ethanolic solution
containing 1 g of citric acid and 0.048 ml of titanium (IV) isopropoxide. Coreshell
CoFe2O4-BaTiO3 MENs were prepared by mixing 0.1 g of CoFe2O4 nanoparticles in the
BaTiO3 precursor solution and the mixture was sonicated for 2 hrs. Once the
CoFe2O4 nanoparticles were thoroughly dispersed, the mixture was dried on the hot plate
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at 60°C overnight while being continuously stirred. The dried powder was heated to
780°C for 5 hrs. in a furnace (CMF-1100) and cooled at 52°C per minute to obtain the
coreshell MENs of ~30 nm diameter. The particles size distribution was measured using
dynamic light scattering method (Malvern-Zetasizer).
Three cancerous cell lines Skov-3 (Ovarian adenocarcinoma), U87-MG
(Glioblastoma), MCF-7A (Breast adenocarcinoma) and two non-cancerous cell lines viz
Brain Endothelial cells (Brain EC) and Rat smooth muscle endothelial cells (RSMC) were
cultured at 37°C as per manufacturer’s instructions. For nanoparticle studies, cells were
detached using 0.25 % trypsin solution, plated in 6 well plates and allowed to grow to 80
% confluency. Magnetoelectric nanoparticles (MEN’s) were resuspended in cell culture
media through sonication and were incubated for 30 minutes. MEN’s were added to each
well at a concentration of 150 μg/ml and the cells were further incubated for 15 hours, to
allow attachment of MEN’s with the cells. Effect of d.c magnetic field was studied by
exposing the cells incubated with MEN’s to a magnet that was placed, at a distance, directly
underneath the culture plate. The distance of magnet from cell culture plate needed to create
100 Oe field was determined using a gauss meter. U87 -MG cells were exposed to field for
6 hours after which the spectra was acquired whereas Brain EC’s and RSMC’s were
exposed to field for 15 hours under MEN incubation. Additionally, all the cell lines were
incubated with 150 μg/ml traditional MNP (CoFe2O4) for 15 hours with and without d.c.
magnetic field. After the end of incubation period, the cells were washed with phosphate
buffered saline (PBS) to remove particles not attached to cells. Cells were scraped from the
bottom of plate and transferred to a 5 mm NMR tube. Continuous wave- 1H NMR readings
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were obtained using a CWS 1250 NMR spectroscope. Sample placement, instrument
parameters (B0, instrument phase,line-width) were carefully selected to ensure optimal
signal to noise ratio. NMR spectra was collected at opposite phases (in our case these were
107° and 297°). The spectra from cells with/without MEN’s was added with opposite phase
signal of PBS to eliminate the solvent interference. The figures below are AFM images of
endothelial cells (height on the left and phase on the right). Figure 35 (b) clearly shows that
the MENs are inside the cells due to magnetic-electroporation when subjected to dc
magnetic field as described earlier.

Figure 35: AFM image pair of endothelial cells (z-height (left), phase (right))
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Figure 36: AFM image pair (z-height (left), phase (right)) of glioblastoma cells (a) without
MENs, (b) with MENs

5.3 Measurement of Cancer Cells
In this study, MENs were integrated into media with different cancer cells and
then their NMR spectrum was measured under equivalent conditions.
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Figure 37: CW-NMR spectra of cells without MENs for ovarian carcinoma cells SKOV-3,
breast adenocarcinoma cells MCF-7 and glioblastoma cells U87-MG.

Figure 37 shows continuous wave NMR curves for three cancer cell lines under
study including glioblastoma cells, ovarian carcinoma cells SKOV-3, and breast
adenocarcinoma cells MCF-7 without any nanoparticle being present in the media. The
NMR signal is measured in the field sweep range from -2.5Gs to +2.5Gs and at a frequency
of 14,000 kHz. It can be noted that the three cell lines don’t significantly differ from each
other.
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Figure 38: CW-NMR Spectra of (a) U87-MG, (b) SKOV-3, (c) MCF-7, and (d) Brain
Endothelial Cells with traditional magnetic nanoparticles

Figure 38 shows continuous wave NMR curves obtained by incubating three cancer
cell lines (a) Glioblastoma, (b) SKOV-3, (c) MCF-7 and a non-cancerous healthy cell line
(d) for 15 hours with traditional magnetic nanoparticles. Each set consists of three curves
including spectra for cells only, cells incubated with MNPs without application of an
external field, and cells incubated with MNPs under application of a 100-Oe d.c. field. The
concentration of the nanoparticles in the media was approximately 150 μg/ml. Similar to
the case without any nanoparticles, neither of the spectra i.e. cells only (solid line), cells
with magnetic nanoparticles (broken lines) and cells with magnetic nanoparticles with
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external magnetic field (dotted broken lines) for the four cell lines significantly differs from
the corresponding cell line without MNs incubation as well as between each other.
However, the above trend drastically changes if MENs are used instead of MNPs.

(a)

(b)

(c)

(d)

Figure 39 CW-NMR spectra of cells incubated with MENs for (a) glioblastoma cells U87MG, (b) ovarian carcinoma cells SKOV-3, (c) breast adenocarcinoma cells MCF-7, and (d)
normal brain endothelial cells

Figure 39 shows CW-NMR spectra obtained by incubating the same three cancer
cell lines and non-cancerous normal cell line for the same amount of time of 15 hours, with
the only exception of having MENs instead of MNPs at the same concentration of
approximately 150 μg/ml. According to these spectra, in great contrast to the traditional
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MNPs, MENs significantly affects a NMR spectrum for each cancer cell type. The only
exception is the non-cancerous endothelial cell line; as MNPs, MENs barely affected the
spectrum.

Figure 40: CW-NMR spectra of Glioblastoma, SKOV-3 and MCF-7 cells (broken lines as
shown in the legend) with MENs and Glioblastoma cells without MENs (solid line)

Figure 40 shows continuous wave NMR curves for the same three cancer cell lines
incubated with MENs without field application under equivalent conditions. The
concentration of the nanoparticles was approximately 150 μg/ml. Unlike the above case
with the traditional MNs, the three cell lines Glioblastoma, SKOV-3 and MCF-7
significantly differ from each other. It can be noted that the difference between the spectra
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is not just quantitative but rather qualitative. Each cell type displays a distinguished set of
peaks in its spectrum thus indicating an intrinsic interaction between MENs and cells. The
spectra of Glioblastoma cells without any MENs (dark solid line) is provided for reference.
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6. SIGNATURE ANALYSIS OF PROTHROMBIN
6.1 Background
As we described in chapter 2, it is imperative to understand the functionality of
proteins in our body that plays a vital role for disease prevention and cure. There are many
applications of nanotechnology on computer engineering, sensing, biology and medicines,
pathogen detection etc. however not much is done specific to functionality of protein that
cause diseases [2-4,21-25]. Most of the nanomedicine technology rely on drug delivery
through blood vessels so the toxicity of nanoparticles has been discussed but not its effect
on the blood coagulation system [26-29]. Heart disease is the leading causes of death in the
world. Ischaemic heart disease, stroke, lower respiratory infections and chronic obstructive
lung disease have remained the top major killer diseases in recent years. It is critically
important to control and monitor the Prothrombin Time (PT) in order to prevent from
possible stroke or clot formation in blood vessels. We attempt to get the signature of
prothrombin and its functionality using magnetoelectric nanoparticles.
6.2 Prothrombin time and international normalized ratio
Prothrombin time (PT) is a blood test that measures the time it takes for the plasma
of your blood to clot. The measurement of prothrombin time depends on the reagent used
in the laboratory. Unlike the standard laboratory test, viscoelastic method (VEM) is based
on the whole blood coagulation available in real time at much faster turnaround time [68].
The prothrombin time is functional determination of the extrinsic (tissue factor) pathway
of coagulation and is sensitive to the vitamin-K dependent clotting factors (factors II, VII,
and X). Tissue factor (factor III) is a transmembrane protein that is widely expressed on
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cells of non-vascular origin, which activates factor VII during the initiation of the extrinsic
coagulation pathway.
Since the prothrombin time varies according to the type of analytical system
employed and the reagent used to perform the test, World Health Organization (WHO)
introduced a standard way called International Normalized Ratio (INR) [69]. Each
manufacturer assigns an International Sensitivity Index (ISI) for any tissue factor they
manufacture as a reagent. The ISI value indicates how a particular batch of tissue factor
compares to an international reference tissue factor. The INR of a patient is given by the
following equation.
𝑃𝑃𝑇 𝐼𝑆𝐼
𝐼𝑁𝑅 = (
)
𝑀𝑁𝑃𝑇
Where, PPT is the Patient Prothrombin Time for the given reagent (ISI), and MNPT
is the Mean Normal Prothrombin Time.
The value of ISI is usually between 1 and 2. The INR of a healthy person is between
0.8 and 1.1 while the physicians recommend it to be between 2 and 3 for therapeutic
patients.
Critically ill patients develop hemostatic abnormalities, ranging from isolated
thrombocytopenia or prolonged global clotting tests to complex defects, such as
disseminated intravascular coagulation. There are many causes of coagulation disorders
depending the kind and condition of patients that require specific therapeutic or supportive
management. In recent years, new insights into the pathogenesis and clinical management
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of many coagulation defects in critically ill patients have been accumulated and optimized
the diagnostic and therapeutic strategy [70].
The use of certain anticoagulant therapy in patients with cases of blood related heart
disease, stroke and pulmonary arterial hypertension (PAH) has been controversial for
decades [71-74]. In this study, with the approved IRB and consent with the patient (the
researcher), we are performing an experiment in human subject using blood sample of
patient with Pulmonary Artery Hypertension WHO group I. The results of Comparative,
Prospective

Registry

of

Newly

Initiated

Therapies

for

Pulmonary

Hypertension (COMPERA) lend support to current recommendations for the use of
anticoagulant therapy in patients with idiopathic PAH, but not in other forms of PAH [7476]. But, it is inevitable that the proper use of anticoagulant lowers the risk of heart failure
provided that there are no other side effects.
6.3 Sample Preparation
MENs was prepared as described in chapter 2.3 with slight modification. CoFe2O4BaTiO3 core shell MENs were prepared according to the following conventional
procedure. As the first step, CoFe2O4 particles were prepared by the standard hydrothermal
method, according to which 0.058 g of Co(NO3)2.6H20 and 0.16 g of Fe(NO3)3.9H20 were
dissolved in 15 ml of distilled water and 0.2 g of polyvinylpyrrolidone was dissolved in 5
ml of aqueous solution containing 0.9 g of sodium borohydride at 120°C for 12 hours.
Then, a precursor solution of BaTiO3 was prepared by mixing 30 ml of aqueous solution
containing 0.029 g of BaCO3 and 0.1 g of citric acid with 30 ml of ethanolic solution
containing 1 g of citric acid and 0.048 ml of titanium (IV) isopropoxide. Coreshell
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CoFe2O4-BaTiO3 MENs were prepared by mixing 0.1 g of CoFe2O4 nanoparticles in the
BaTiO3 precursor solution and the mixture was sonicated for 2 hrs. Once the CoFe2O4
nanoparticles were thoroughly dispersed, the mixture was dried on the hot plate at 60°C
overnight while being continuously stirred. The dried powder was heated to 780°C for 5
hrs. in a furnace (CMF-1100) and cooled at 52°C per minute to obtain the coreshell MENs
of ~30 nm diameter. The particles size distribution was measured using dynamic light
scattering method (Malvern-Zetasizer).
Blood sample was taken via finger prick from a patient of Pulmonary Arterial
Hypertension, WHO Group I. The blood sample was taken in a pipette and gently
transferred into a micro centrifuge tube containing MENs. Details are in the following
chapter.
6.4 Measurement of therapeutic blood
Blood consist of erythrocytes or red blood cells (RBC), leukocytes or white blood
cells (WBC), and thrombocytes or platelets in plasma. It contains ferromagnetic materials
especially in RBCs that is expected to interact with MENs. Most of the therapeutic drug
used to control PAH is routed via blood so as the drug coated magnetoelectric nanoparticles
(MENs). Interestingly, there is very little or none interaction of MENs on blood cells rather
the experiment shows a significant effect on PT/ INR of the blood. Our objective is to
analyze the interaction of MENs with the INR of therapeutic blood or other blood
constituents especially the hemoglobin or hematocrit. With the approval of IRB protocol
and consent from the Office of Research Integrity at FIU and all required trainings for
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Human Subject Research, therapeutic blood sample of a pulmonary arterial hypertension
patient is taken for the study.
Sample of blood from a PAH patient, New York Heart Association (NYHA)
Functional Class III, was collected via finger prick. The measured INR of the blood was
2.9, hemoglobin 18.9 gm/dL and hematocrit 58%. After treating with MENs of
concentration 50 mg/mL, the INR increased to 4.1 however, the aftermath measurement of
INR will not reflect the actual reading due to time exposed and concentration of the sample.
The cougulometer may not function properly under such environment. It may indicate that
the MENs has higher impact on the prothrombin time of blood. From the engineering
prospective, experiments show a distinct signature of INR of therapeutic blood using
MENs. In-depth analysis using molecular dynamics computational simulation will give the
actual interaction mechanism of MENs on prothrombin. Currently, we are working to
understand the underlying physics behind it. We tried to measure the INR with the lower
concentration of MENs but failed to get the readings from cougulometer. A measured
amount of citrate was added as a reversible anticoagulant to study its interaction with the
nanoparticles using NMR.
25 L of MENs Concentration 50 mg/mL was taken in a micro centrifuge tube with
equal amount of therapeutic blood sample. Out of the sample, only one capillary was taken
for NMR measurement. The CW-NMR spectrometer results are shown in the following
graphs along with their signature curves.
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CW-NMR Spectra of 10 nm MENs
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Figure 40: Comparison of 10 nm MENs background (blue) and MENs with blood sample
(red)
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Figure 41: Signature curve of 10 nm MENs with sample blood
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CW-NMR Spectra of 30 nm MENs
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Figure 42: Comparison of 30 nm MENs background (green), MENs with blood sample
(blue) and MENs and blood sample with magnetization (red)

Signature Curve of 30nm MENs Blood Mag
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Figure 43: Signature curve of 30 nm MENs with sample blood (blue) and MENs and sample
blood with magnetization (red)

Temporary magnetization of MENs (red) does effect the surface interaction with blood
constituents but not significantly.
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CW-NMR Spectra of 100 nm MENs
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Figure 44: Comparison of 100 nm MENs background (blue), MENs with blood sample (red)
and MENS and blood sample with magnetization (green)

Signature Curve of 100 nm MENs Blood Mag
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Figure 45: Signature curve of 100 nm MENs with sample blood (blue) and MENs and
sample blood with magnetization (red)
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As usual, X-axis in Gs and Y-axis is in arbitrary units. Figure 42 shows the efficacy
of 30 nm MENs is greater than 10 nm (Figure 40) and 100 nm (Figure 44). Moreover,
temporary magnetization does not have significant effect on the signature curve.
For further study we chose 30nm MENs for the experiment due to its higher efficacy.
The blood sample of therapeutic patient was taken by finger prick as in the previous
experiment with measured INR 1.4. Next, 500 L of blood sample with the concentration
of 500g/mL of MENs was taken in a NMR tube for measurement. Figure 46 shows the
CW-NMR spectra of the blood sample (INR 1.4) with MENs. Sample placement,
instrument parameter like B0, phase, and line width were carefully selected to ensure
optimal signal to noise ratio. NMR spectra was collected at opposite phases 107° (blood
with MENs) and 297° (background). The spectra from blood sample and MENs
background was added with opposite phase signal to eliminate the possible solvent
interference. Field sweep was taken as 50 Gs with the frequency of 14,000 kHz.
The INR of therapeutic patients varies depending on the physical activity, diet and
various other factors so INR should be monitored such that it does not go down to around
1 or up to around 4. The patient has been monitored with prescribed warfarin from 5 mg to
7.5 mg per day since last several years. During regular checkup, at a point when the
measured INR was 1.4, we took the blood sample and used for CW-NMR spectra. It is hard
to keep diet (especially that interferes with vitamin K), exercise, supplemental oxygen, and
other physical activities as normal for such an active patient so it is evident that the INR
varies from time to time, therefore it needs to be monitored every 2 to 4 weeks and change
the dose of warfarin accordingly. At some other time when the INR was 3.1, the blood
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sample was taken again for measurement. Same as before, 500 L of blood sample with
the concentration of 500 g/mL of MENs was taken in a NMR tube for measurement.
Figure 47 shows the CW-NMR spectra of the blood sample (INR 3.1) with MENs.

CW-NMR Spectra- blood of INR 1.4
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Figure 46: CW NMR Spectra of MENs with therapeutic blood of measured INR 1.4
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CW-NMR Spectra- blood of INR 3.1
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Figure 47: CW NMR Spectra of MENs with therapeutic blood of measured INR 3.1

Signature Comparison of Blood sample with
INR 1.4 and 3.1
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Figure 48: CW-NMR Signature comparison of blood samples with measured INR 1.4 (blue)
and 3.1 (red)

Figure 48 shows that the signature of blood with lower INR (1.4) has greater intensity
compare to the higher INR (3.1). Higher INR means thin blood where only few linkers
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connecting kringles of prothrombin are active. Lower INR means dense blood that has high
efficacy with the MENs so that we can see a significant peak in the graph. We are in the
process of performing high resolution computational molecular dynamics simulation
which may reveal the in-depth understanding of molecular mechanism of the system.
6.5 Loess Method
Most of the times we used Loess Method for the graph plot. There are several
methods of smoothing the curves where moving averages is widely used by engineers when
the variables are somewhat linearly distributed. We attempt to use an alternate way, mostly
used by economists, called Loess method that strongly relates to non-parametric
regression methods that combine multiple regression models in a k-nearest-neighbor-based
meta-model. It can also be referred as LOcal regrESSion. In the loess method, weighted
least squares are used to fit linear or quadratic functions of the predictors at the centers of
neighborhoods. The radius of each neighborhood is chosen so that the neighborhood
contains a specified percentage of the data points. The fraction of the data, called the
smoothing parameter, in each local neighborhood controls the smoothness of the estimated
surface. Data points in a given local neighborhood are weighted by a smooth decreasing
function of their distance from the center of the neighborhood. SAS Analysis with the
LOESS Procedure and dependent variable: yax is the intensity in arbitrary units.
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Figure 49: Selection of smoothing parameter
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Figure 50: Figure 5.5: Curve fitting with smoothing parameter 0.053

Smoothing parameter was found to be 0.053 from Figure 44. Figure 45 shows the
best fit curve along with all the data points.
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There is no significant interaction of blood constituents with magnetoelectric
nanoparticles and is save to use in medical applications however, the PT- INR shows a
significant increment which could in other way be beneficial for the patients in terms of
anticoagulation therapy.
6.6 Sample blood with MENs coated with GMO and EDC
Another sample of blood from the same subject is collected via finger prick. The
measured INR of the blood was 2.8, hemoglobin 19.0 gm/dL and hematocrit 58%. After
treating with MENs of 2.5 mg, the Coagulation Meter showed the INR of 5.0. We must
take into account that the time exposed to the blood after treating with MENs and the
concentration of the blood have significant effect on INR and the coagulation meter will
not reflect the actual value of PT or INR. The sample were treated MENs with GMO (GMO
coated MENs sample preparation is discussed in Chapter 2.3.3) and with EDC separately.
20uL of MENs Concentration 50mg/ml was taken in a micro centrifuge tube with 30uL of
therapeutic blood sample.

Since this study is only to find the interaction of two intermediate layers GMO and
EDC, and the CW-NMR spectra is significantly different, here we have shown the direct
plot without using Loess Method for signal smoothing.
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CW-NMR Spectra of Blood sample with 10 nm coated
MENs
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Figure 51: Comparison of GMO and EDC coated 10 nm MENs with blood sample

CW-NMR Spectra of Blood Sample with 100 nm
coated MENs
150
100
50
0
-3

-2

-1

-50

0

1

2

3

-100
-150
-200
-250
GMO

EDC

Figure 52: Comparison of GMO and EDC coated 100 nm MENs with blood sample
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It is clear that the MENs can also acts as a contrasting agent and safe and non-toxic
to human blood however, the computational Physics, molecular dynamics study will
explain what triggers the molecular mechanism of blood constituents that results in
increment of PT/ INR. The graphs Figure 51 and Figure 52 are CW-NMR spectra of GMO
and EDC coated MENs of size 10nm and 100nm respectively. EDC coated MENs can
better function for the signature of not only therapeutic blood sample but also with other
biomolecular organisms. Currently, we are working with the Theoretical BioPhysics Group
at the department of Physics at FIU to find out the underlying mechanism of molecular
dynamics of prothrombin and nanoparticles interaction.
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7. DISCUSSION
The above experiments have clearly demonstrated that MENs are uniquely
positioned to distinguish different cells and mircoorganisms from each other through
identification of the samples’ electric-field properties at the subcellular level. In this study,
MENs have been compared to traditional magnetic nanoparticles which don’t display any
magnetoelectric effect and thus, unlike MENs, don’t produce any significant magneticfield-dependent electric field of their own. In other words, the experiments have proven
that it is the presence of the unique ME effect which sets MENs apart from all the other
nanoparticle types and turn them into a superior diagnostic tool. To demonstrate the
fundamental nature of this diagnostic approach, three independent applications have been
studied including identification of blood cells, bacteria, and cancer cells. All three types of
aforementioned biomolecular organisms can have vital impacts on the modern state of
disease prevention and life quality. To present the underlying story, this discussion will
focus on one particular application: cancer cells. For example, in Chapter 5, the
significance of the cancer related application cannot be underestimated. Again, only
MENs, not traditional purely magnetic nanoparticles, could detect the fine NMR spectral
features which originate from complex intrinsic charge configuration on the membrane
surface of a specific cell type.
The following back-of-the-envelope model could give an idea of the underlying
physics of the diagnostic of cancer cells with MENs. When nanoparticles are placed in any
cellular media, they bind to characteristic sites of the surface of cellular membrane such
that the electric and chemical energy are minimized. Indeed, this could be seen in AFM
images which clearly showed the nanoparticles “stick” to ruptured regions on the
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glioblastoma cellular membrane surface. In contrast, the normal endothelial brain cell
membranes displayed a relatively continuous rupture-free surface with no preferential
binding sites. In case of a MEN, depending on the binding site, the intrinsic electric field
is affected in a certain way due to the electrostatic and chemical bonds at this site. Because,
unlike the traditional MNs, MENs have a non-zero electric dipole, the electrostatic bonds
can be particularly strong. Previously, MENs were shown to acquire a non-zero surface
charge due to the double-layer chemistry in the cellular microenvironment. Due to the ME
effect the resulting change in the electric field would trigger a change in the magnetic
moment of the nanoparticle, which in turn would induce a change of the local magnetic
field at this particular location. Considering there are many nanoparticles, they would
preferentially bind to all the characteristic sites and thus would change the net magnetic
field in a very specific way depending on the cell type. Thus, the effect could be quantified
according to the following formulation.
At each binding site, the NMR signal, e.g. the electromagnetic energy absorption,
is generated when the following resonance condition is satisfied: h = MnHnet, where h is
the Plank constant,  is the frequency of the electromagnetic wave, Mn is the magnetic
moment due to the nuclear spin (in this study, the proton spin), Hnet is the net magnetic
field at this location. This local net field is made of the two contributions, the external field
generated by the NMR magnets, H0, and the field due to the ME effect of MENs at the
location, HME, respectively:
Hnet = H0 + HME.

73

To a zeroth approximation, according to the ME dependence, in the vicinity of a
nanoparticle, HME ~ MS = αE, where MS is the nanoparticle’s saturation magnetization, α is
the ME coefficient, and E is the electric field in the vicinity of the nanoparticle. In turn,
this electric field depends on the cell membrane morphology and the interaction between
the binding site and the nanoparticle. Assuming an electric field, E, on the order of 1000
V/cm, a ME coefficient, α, of 10 mVcm-1Oe-1, according to the ME expression, the induced
local magnetic field, HME, could be on the order of 10 Oe, which would make a significant
contribution to the NMR signal. The NMR bias field, H0, is on the order of 2,000 Oe. Here,
it should be noted that the additional ME-induced field is very local, with a localization
length defined by the MEN’s average size of approximately 30 nm. So, although the local
induced fields are quite significant, the average effect in the relatively large NMR setup
could be much smaller. According to this analysis, it can be seen that due to the ME effect,
when an external magnetic field is swept in a 5-Oe range around the bias field during each
NMR measurement, the measured spectrum should reflect contributions of MENs from
different binding sites. That is the reason why we see a significant dependence on the cell
type when MENs are placed into cancer media. Again, it can be noted that the traditional
purely magnetic nanoparticles, which don’t display any ME effect, couldn’t provide this
intrinsic contribution specific to each cell type, despite the fact that their saturation
magnetization is almost two orders of magnitude higher than that for MENs. In a way,
MENs allow to translate the intrinsic electric-field configuration on the cell membrane at
the subcellular level into an easily measurable signature NMR signal specific to this
particular cell type.
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The same physics could be used to explain the observed MENs-affected NMR
spectra in the other two applications under study, i.e., for blood cell and bacteria
identification.
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8. CONCLUSION
MENs could be used to distinguished between different types of bacteria, viruses,
blood cells, cancer cells and their normal counterparts at the subcellular level.
The above experiments on bacteria, cancer cells, and prothrombin clearly showed
that MENs could be used not only to distinguish between the organisms from their normal
counterparts but also to identify different organisms. In other words, the experiment on
cancer cells showed that MENs could be used not only to distinguish between cancer cells
from their normal counterparts but also to identify different cancer cell lines. Different cells
have different surface topography with different binding sites for nanoparticles. In addition,
the surface morphology depends on the cell progression. In other words, the NMR signal
modified by MENs in the cell media is complex and made of several components. The
nanoparticles can be found on the cell membrane surface as well as inside the cell, as
confirmed through AFM analysis. An important observation is the fact only MENs, due to
the ME effect, could be used to provide such a signature identification at the subcellular
level. For comparison, traditional magnetic nanoparticles with no ME effect couldn’t
provide such a precise diagnostic capability.
Optimization and proper calibration of MENs concentration, sample preparation,
precise measurement and proper signal processing application design will further enhance
the signature identification of biomolecules. It has been proven that exploitation of intrinsic
surface electromagnetic properties of biological organism and utilization of the nuclear
magnetic resonance property can enable a cost effective and portable tool for biomedical
signature and screening.
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9. FUTURE WORK
Experimentally, we have shown the clustering of microorganisms with MENs and
their magnetoelectric contribution leading to signature identification. We are working on
the study of molecular interaction using free software called VMD (Visual Molecular
Dynamics) and NAMD (Nanoscale Molecular Dynamics) simulation that can lead to an
in-depth analysis of MENs interaction with microorganisms. Recently, theoretical
biophysics group at FIU showed that Ebola virus protein hexamer enhances the clustering
of certain lipids in the plasma membrane [77]. IBM group has shown the potential
interference of protein-protein interactions by graphene using computation molecular
dynamics [78]. Nobody has done any theoretical research on MENs interaction with
protein. We are using PDB (Protein Data Bank) file of prothrombin to study the interaction
of MENs that can not only potentially explain our experimental result but also lead to
possible treatment of blood related diseases.
Moreover, we move forward from the use of magnetoelectric nanoparticles;
paradigm shift from diagnostics to treatment. With the approved IACUC, we are currently
working on in-vivo experiment of MENs for PH in mouse model. The arteries are complex
in structure; however, we take a simple mechanical model and try to get the stiff PASMC
back into normal.
The modal is based on the Navier-Stokes equation for incompressible flow,
𝜕𝑣

𝜌 ( 𝜕𝑡 + 𝑣. ∇𝑣) = −∇p + μ∇2 𝑣 + 𝑓. Continuity equation for incompressible blood flow,
∇. 𝑣 = 0 ( being constant)
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Finite Element Method (FEM) simulation modelling was performed to study the
variation of blood pressure due to stiffness of arteries.
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Figure 53: Deformation of arteries with neo-hookean coefficient.

The graph in Figure 53 shows that the stiff arteries get less relaxed due to the pressure of
blood compared to normal arteries.
The magnetic dipole moment of PASMC depends on the magnetic orientation of the cell’s
1

1

magnetic dipole 𝑑~𝛼 ′ 𝐻 and ℎ~ 𝑑𝑡 ~ (𝛼′ 𝐻)𝑡, (proposed Khanal’s equation) where the value
of t ranges from 0.3 to 2.

Furthermore, most of the effective vasodilators, specially prostacyclin (PGI2)
synthetic analogues have very low half life in plasma. Knowing the fact that less than 1%
of current PH drugs is delivered to the targeted diseased PASMC. Our approach is to
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deliver 100% of the drug to specific cells. Firstly, we perform in vitro experiments to bind
such PH drugs in the smart nanoparticles for targeted delivery on diseased cells. We
approach to pre-program the self-triggering mechanism via defining the MENs saturation
magnetization and the magneto-electric (ME) coefficient through a fabrication process or
via application of an external magnetic field.

Figure 54: Schematic diagram of drug loaded MENs with critical field entering PASMC

Figure 54 depicts the MEN as field controlled nano-electroporation sites to let the
drug pass through the endothelial cells and delivered to PASMC. At the threshold field Hth,
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the drug loaded MEN enters PASMC, and as the field increases further, the release of the
drug from MEN is initiated.

In collaboration with theoretical biophysics research group at the department of
physics at FIU and Miami Cardiovascular Institute, Baptist Health South Florida, we are
in process of working on finding a new drug on MENs that can potentially cure PAH.
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